Q1 2022

Filed May 16, 2022 · 10-Q · 46 days after period end · 0001477932-22-003424

Q1 2022 · 10-Q

Revenue

$20.52K

+102.7% vs Q1 2021

Net Income

-$944.99K

N/M vs Q1 2021

EPS, diluted—

Operating Income-$1,124,674N/M

Operating Cash Flow-$872,672N/M

Same quarter

Metric	Q1 2022	Q1 2021	Q1 2020	Q1 2019
Revenue	$20.52K	$10.12K	$36.90K	$65.27K
Net Income	-$944.99K	-$1.58M	-$1.08M	-$1.77M
EPS Diluted	—	-$0.26	-$0.20	-$0.67

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

BioCorRx Inc. · CIK 1443863 · Engraved from SEC EDGAR